The Body in Flux: How Universal Standard is Redefining Retail in the Age of GLP-1

As the landscape of the fashion industry undergoes a seismic shift, the rise of GLP-1 agonists—the class of weight-loss drugs including Ozempic, Wegovy, and Zepbound—has sparked a complex debate regarding the future of sizing, inclusivity, and consumer behavior. While many legacy luxury brands seem to be retreating from the progress made in size inclusivity, Universal Standard is leaning into the volatility. By viewing the shifting bodies of their customers not as a merchandising hurdle, but as a permanent evolution of the modern wardrobe, the brand is proving that inclusivity is a business imperative, not a passing trend.

The Capsule: A Case Study in Adaptive Design

In September, Universal Standard launched "US x Abisola," a seven-piece capsule collection designed in collaboration with London-based creative director and influencer Abisola Omole. The collection, which spans a staggering size range of 00 to 40, serves as a direct retort to the shrinking size curves seen on the runways of New York, London, Milan, and Paris.

Priced between $150 and $225, the collection focuses on foundational pieces—tailoring, knitwear, and versatile separates—designed to function as a cohesive wardrobe. The market response was immediate and telling. Within the first 48 hours of launch, nearly 60% of the collection’s initial unit sales on the brand’s U.S. direct-to-consumer (DTC) site were finalized. Customers demonstrated a clear preference for coordinated looks, purchasing an average of 1.7 pieces per order. The $225 Ponte Blazer and the $165 Ponte Wrap Pant emerged as the collection’s "power couple," frequently bought together.

The data further debunked the myth that extended-size consumers only shop for basic, entry-level items. The $150 Soft Spun Polo Sweater accounted for one-third of units sold, and nearly 90% of all units were purchased in size 14 or above, with the 18–24 range accounting for over half of total volume. This performance suggests that the consumer is not looking for "tents" or temporary fixes; they are looking for high-quality, aspirational fashion that fits their body as it exists today.

Chronology: From Concept to Runway Resistance

The partnership between Omole and Universal Standard began with a simple, public declaration. In May 2025, Omole posted a "birthday wish list" on Instagram, expressing a desire to design a truly inclusive collection. Universal Standard reached out within days. What followed was a 16-month development process that prioritized technical precision over the industry-standard practice of "scaling up" straight-size patterns.

Unlike many brands that design for a size 6 and mathematically extrapolate the measurements for a size 22—often resulting in poor fit—Universal Standard begins its design process at size 18. This "Medium-first" philosophy ensures that the structural integrity of a garment is maintained across the entire size spectrum.

During the September 2027 Fashion Month, the contrast between the US x Abisola collection and the global runway shows could not have been starker. While Omole wore her pieces to industry events, she noted that representatives from major fashion houses often struggled to confirm whether their own collections even offered extended sizing. "We’re given this whole spiel of, ‘Things aren’t possible. Things are too expensive. Things are too technical,’" Omole said. "But you can build the infrastructure and make it happen. You’re just choosing not to."

Supporting Data: The GLP-1 Consumption Shift

The urgency of this conversation is fueled by a rapid change in the American consumer profile. According to PwC research leveraging Numerator data, the prevalence of GLP-1 usage in U.S. households jumped from 9% in early 2025 to 21% by May 2026. Crucially, 73% of these users report a "meaningful change" in their clothing size.

Contrary to the fear that these consumers would stop spending, the data reveals a "rebirth" of shopping habits. Apparel spending among GLP-1 users increased by 9.9% after six to eight months of treatment. Spending on women’s jeans—a notoriously difficult category to fit—surged by 66.1%. Jewelry, swimwear, and dresses also saw double-digit growth.

Ali Furman, consumer markets industry leader at PwC US, emphasizes that this is not a shift toward "budget" shopping. "They’re buying from the same part of the price ladder before and after starting the drug," Furman explains. "Instead, they are buying new sizes within familiar categories and returning to products they had previously avoided, including dresses, swimwear, and intimates." The challenge for retailers is not a loss of demand, but a loss of reliability in traditional inventory planning.

Official Responses: Navigating the "Size Void"

For Universal Standard, the solution to this market volatility is the "Fit Liberty" program. Launched to address the anxiety of fluctuating body sizes, the program allows customers to exchange eligible clothing for a new size within one year, even after the garments have been worn.

"Buy for now. Buy the size that you are now and enjoy the fashion," says Ramon Martin, Universal Standard’s chief creative officer. "If that changes, we’re here for you, too."

This approach stands in direct opposition to the current trend in luxury and high fashion. Recent data from size-inclusivity campaigner Felicity Hayward paints a grim picture of the runways: at the Spring 2027 shows across the "Big Four" fashion capitals, only 115 looks out of 11,550 featured curve or plus-size models. That is roughly 1% of the total, with some cities, like London, seeing a 56% decline in curve representation compared to previous seasons.

Critics, including Omole, argue that the rise of GLP-1 drugs is being used as a convenient excuse for this retreat. "I think there’s something to be said about this industry almost using it as a scapegoat or an excuse to double down on not being inclusive," Omole stated. "That’s the part I don’t like."

Implications for the Future of Retail

The implications for the broader retail industry are significant. If, as PwC suggests, consumers are frequently moving between sizes, retailers must rethink their entire operational model. The "static" size curve is becoming an artifact of the past.

For brands looking to survive this transition, several strategies are becoming clear:

1. Investment in Technical Expertise: Brands must move away from grading patterns from a small base. As Universal Standard has shown, starting at a mid-to-large size ensures better fit and garment longevity.
2. Redefining Customer Service: Retailers need to train associates to assist customers through significant body changes. This includes offering in-store alterations and, perhaps, adopting exchange-friendly policies like Fit Liberty to reduce the financial risk for the consumer.
3. Reframing the Narrative: The industry must stop treating size fluctuation as a temporary "phase" that requires cheap, disposable clothing. As the data shows, these customers are willing to spend, but they demand the same quality, tailoring, and design sophistication as their straight-size counterparts.

Universal Standard’s success—generating nearly $200 million in gross sales and maintaining a repeat-customer rate of 80% as of 2024—serves as a blueprint. Their business is built on the reality of the human body, which is rarely static.

As the fashion industry grapples with the impact of GLP-1s, it faces a choice. It can continue to chase an idealized, narrow vision of the human form, or it can accept that the most profitable and relevant path forward lies in acknowledging the fluidity of the customer. For Universal Standard, the bet is clear: inclusivity is not a social cause to be abandoned when trends shift—it is the very foundation upon which the future of retail must be built.